Zobrazeno 1 - 10
of 13
pro vyhledávání: '"and Valentina Galfo"'
Publikováno v:
Antibiotics, Vol 12, Iss 8, p 1316 (2023)
Despite recent advances in the transplant field, infectious complications after orthotopic liver transplantation (OLT) are major causes of morbidity and mortality. Bacterial intra-abdominal infections (IAIs) are predominant during the first month pos
Externí odkaz:
https://doaj.org/article/e7033145ada944a890fe51c817739f31
Autor:
Marco Falcone, Lorenzo Roberto Suardi, Giusy Tiseo, Chiara Barbieri, Lisa Giusti, Valentina Galfo, Arianna Forniti, Claudio Caroselli, Leonardo Della Sala, Sara Tempini, Chukwuma Okoye, Fabio Monzani, Francesco Menichetti
Publikováno v:
Clinical Therapeutics
Purpose: Preliminary data suggest that remdesivir may influence the course of COVID-19 according to the duration of pre-admission symptoms. We aim to evaluate whether early use of remdesivir is associated with a reduced COVID-19 progression in a homo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8feaea2ee8543268a3153a17b8f8c0b
https://doi.org/10.1016/j.clinthera.2022.01.007
https://doi.org/10.1016/j.clinthera.2022.01.007
Publikováno v:
Infection.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bfb36b420154fc186e2c3a29760c709a
https://doi.org/10.1007/s15010-023-01990-4
https://doi.org/10.1007/s15010-023-01990-4
Autor:
Giusy Tiseo, Chiara Barbieri, Valentina Galfo, Sara Occhineri, Tommaso Matucci, Francesco Almerigogna, Jona Kalo, Pietro Sponga, Mario Cesaretti, Gabriele Marchetti, Arianna Forniti, Claudio Caroselli, Simone Ferranti, Manuela Pogliaghi, Marina Polidori, Silvia Fabiani, Stefano Verdenelli, Enrico Tagliaferri, Niccolò Riccardi, Lorenzo Roberto Suardi, Claudia Carmignani, Serena Batini, Luca Puccetti, Riccardo Iapoce, Francesco Menichetti, Marco Falcone
Publikováno v:
Infectious diseases and therapy.
Different antivirals are available for the treatment of outpatients with COVID-19. Our aim was to describe a real-world experience of outpatient management of COVID-19 subjects at high risk of progression.This prospective observational study conducte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f3f5cbfdadb09f373e18a77d27799d2
https://pubmed.ncbi.nlm.nih.gov/36441485
https://pubmed.ncbi.nlm.nih.gov/36441485
Autor:
Giusy Tiseo, Lorenzo Roberto Suardi, Lisa Giusti, Arianna Forniti, Claudio Caroselli, Valentina Galfo, Sara Occhineri, Alessandro Leonildi, Giovanna Moscato, Francesco Menichetti, Marco Falcone
Publikováno v:
Respirology (Carlton, Vic.). 27(11)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a4bdb7c3604b3cdb2aa51ae70c6a512
https://pubmed.ncbi.nlm.nih.gov/36113869
https://pubmed.ncbi.nlm.nih.gov/36113869
Autor:
Marco Falcone, Lorenzo Roberto Suardi, Giusy Tiseo, Valentina Galfo, Sara Occhineri, Stefano Verdenelli, Giancarlo Ceccarelli, Melita Poli, Marco Merli, Davide Bavaro, Anna Carretta, Giuseppe Nunnari, Emmanuele Venanzi Rullo, Enrico Maria Trecarichi, Chiara Papalini, Antonina Franco, Rosa Fontana Del Vecchio, Vincenzo Bianco, Rodolfo Punzi, Daniela Francisci, Raffaella Rubino, Carlo Torti, Massimo Puoti, Sergio Carbonara, Antonio Cascio, Annalisa Saracino, Teresa Santantonio, Mario Venditti, Francesco Menichetti
Publikováno v:
JAC-Antimicrobial Resistance. 4
Objectives To describe clinical characteristics and outcomes of COVID-19 patients who developed secondary infections due to carbapenem-resistant Enterobacterales (CRE). Methods Retrospective observational study including COVID-19 patients admitted to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::523ec4064912b4bf51048ab261b262e4
https://doi.org/10.1093/jacamr/dlac064
https://doi.org/10.1093/jacamr/dlac064
Autor:
Yelin, D, Margalit, I, Nehme, M, Bordas-Martínez, J, Pistelli, F, Yahav, D, Guessous, I, Durà-Miralles, X, Carrozzi, L, Shapira-Lichter, I, Vetter, P, Peleato-Catalan, D, Tiseo, G, Wirtheim, E, Kaiser, L, Gudiol, C, Falcone, M, Leibovici, L and on behalf of the LongCOV Research Group: Dorit Shitenberg, Tanya, Babich, Talya, Kalfon, Michal, Mor, Yair, Shafir, Hadar, Agmon, Ori, Tishler, Donna, Abecasis, Nitzan, Karny-Epstein, Alaa, Atamna, Vered, Daitch, Laura, Tavanti, Chimera, Davide, Fideli, Antonio, Margherita, Biagini, Alessandra, Pagano, Roberta, Pancani, Massimiliano, Desideri, Nicoletta, Carpenè, Luciano, Gabbrielli, Maurizio, Lucchesi, Celi, Alessandro, Micol, Micheli, Ghiadoni, Lorenzo, Barbieri, Greta, Chiara, Romei, Annalisa, Deliperi, Monzani, Fabio, Ferruccio, Aquilini, Michele, Cristofano, Valentina, Galfo, Menichetti, Francesco, Barbieri, Chiara, Alba, Bergas, Vanessa, Vicens-Zygmunt, Cristina, Orive-Lago, Meritxell, Regi-Bosque, Ana, Peñalver-Garcia, Antonia, Requesens-Catalan, Nuria, Perez-Gutiérrez, Giovanna, Miranda, Barbara, Navarro, Eva, Alonso-Bes, Olga, Bella, Enilda, Cordero, Elena, Carrera-Izquierdo, Sonia, Martínez-Carmona
Publikováno v:
Journal of Clinical Medicine; Volume 11; Issue 4; Pages: 898
Dipòsit Digital de la UB
Universidad de Barcelona
Dipòsit Digital de la UB
Universidad de Barcelona
Background: Long COVID has become a burden on healthcare systems worldwide. Research into the etiology and risk factors has been impeded by observing all diverse manifestations as part of a single entity. We aimed to determine patterns of symptoms in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7e65f029772bdf2b476afa3a3997b62
https://pubmed.ncbi.nlm.nih.gov/35207171
https://pubmed.ncbi.nlm.nih.gov/35207171
Autor:
Simona Barnini, Francesco Menichetti, Enrico Tagliaferri, Marco Falcone, S. Sani, Valentina Galfo, Alessio Farcomeni, Dimitrios Bassoulis, George L. Daikos, Cesira Giordano, Alessandro Leonildi, Lorenzo Ghiadoni, Giusy Tiseo
BackgroundIn vitro data support the use of combination of aztreonam (ATM) with ceftazidime-avibactam (CAZ-AVI), but clinical studies are lacking. The aim of our study was to compare the outcome of patients with bloodstream infections (BSIs) due to me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a75b396032c4c3fd452aa1b7fe67401a
http://hdl.handle.net/2108/278118
http://hdl.handle.net/2108/278118
Autor:
Marco Falcone, Antonello Di Paolo, Alessandro Leonildi, Dario Cattaneo, Sara Baldelli, Giusy Tiseo, Manjunath P. Pai, Francesco Menichetti, Valentina Galfo, Enrico Tagliaferri
Publikováno v:
J Antimicrob Chemother
Background Avibactam is a β-lactamase inhibitor that is combined with aztreonam against Enterobacterales co-expressing serine- and metallo-β-lactamases (MBL). Optimal dosing of aztreonam with avibactam is not well-defined in critically ill patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb960d412f979cfdf086524e1dadd32e
https://pubmed.ncbi.nlm.nih.gov/33378458
https://pubmed.ncbi.nlm.nih.gov/33378458
Autor:
Luigi Francesco, Saccaro, Valentina, Galfo, Simone, Ferranti, Alessandro, Russo, Francesco, Menichetti
Publikováno v:
Le infezioni in medicina. 28(2)
Invasive pulmonary aspergillosis (IPA) is a life-threatening condition that usually occurs in immunocompromised hosts. However, according to recent reports it can affect immunocompetent hosts with severe influenza infection due to viral-dependent dis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::59bbcba5177b820d7c3f614a0520ccef
https://pubmed.ncbi.nlm.nih.gov/32487793
https://pubmed.ncbi.nlm.nih.gov/32487793